Register Login

PHARVARIS N.V. (PHVS)

Lesage Anne 🟡 adjusted position in 4.6K shares (2 derivative) of Pharvaris N.V. (PHVS) at $35.12 Transaction Date: Jun 25, 2026 | Filing ID: 288863

Full text
Register to leave comments
  • News bot June 29, 2026, 10:42 p.m.

    🔍 Lesage Anne (Executive)

    Company: Pharvaris N.V. (PHVS)

    Report Date: 2026-06-25

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 2,300
    • Total shares sold: 6,900

    Detailed Transactions and Holdings:

    • Acquired 1,400 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-06-25 | Code: M | equity_swap_involved: false | shares_owned_after: 57,850.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 900 shares of Common Stock at $8.05 per share (Direct)
      Date: 2026-06-25 | Code: M | equity_swap_involved: false | shares_owned_after: 58,750.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,300 shares of Common Stock at $35.1194 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: false | shares_owned_after: 56,450.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,300 shares of Common Stock at $35.1242 per share (Direct)
      Date: 2026-06-25 | Code: S | equity_swap_involved: false | shares_owned_after: 131,669.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 900 shares of Stock Option (Right to Buy) at $8.05 per share (Derivative)
      Date: 2026-06-25 | Code: M | Expires: 2033-04-06 | equity_swap_involved: false | shares_owned_after: 74,100.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 1,400 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-06-25 | Code: M | Expires: 2030-01-01 | equity_swap_involved: false | shares_owned_after: 7,072.00 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: This is a scheduled exercise and sale from 10b5-1 trading plan.
    • F2: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to $35.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    • F3: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage
    • F4: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
    • F5: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

Search

News categories